Sarah Temple

1.2k total citations · 1 hit paper
16 papers, 953 citations indexed

About

Sarah Temple is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Sarah Temple has authored 16 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Hepatology and 4 papers in Oncology. Recurrent topics in Sarah Temple's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Alcohol Consumption and Health Effects (2 papers). Sarah Temple is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Alcohol Consumption and Health Effects (2 papers). Sarah Temple collaborates with scholars based in United States. Sarah Temple's co-authors include Jessica A. Davila, Hashem B. El‐Serag, Fasiha Kanwal, Sahil Mittal, Yvonne H. Sada, Zhigang Duan, Sarah May, Peter Richardson, Jennifer R. Kramer and Jun Ying and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of Hepatology.

In The Last Decade

Sarah Temple

16 papers receiving 939 citations

Hit Papers

Hepatocellular Carcinoma in the Absence of Cirrhosis in U... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Temple United States 6 761 652 144 114 113 16 953
Maki Tobari Japan 12 854 1.1× 513 0.8× 287 2.0× 107 0.9× 91 0.8× 31 974
Janine Graham United Kingdom 4 525 0.7× 433 0.7× 110 0.8× 69 0.6× 127 1.1× 5 662
Gi‐Ae Kim South Korea 16 1.3k 1.7× 1.1k 1.7× 144 1.0× 117 1.0× 134 1.2× 43 1.5k
Jinna Chu United States 5 526 0.7× 366 0.6× 135 0.9× 72 0.6× 76 0.7× 6 646
Luminita Bonyhay France 7 575 0.8× 477 0.7× 180 1.3× 79 0.7× 50 0.4× 12 765
Ariel Feldstein United States 2 886 1.2× 538 0.8× 305 2.1× 124 1.1× 96 0.8× 6 989
B. Mccolgan United States 10 682 0.9× 422 0.6× 266 1.8× 135 1.2× 29 0.3× 23 821
Yeonjung Ha South Korea 17 472 0.6× 518 0.8× 58 0.4× 82 0.7× 126 1.1× 50 848
P J Winwood United Kingdom 9 396 0.5× 494 0.8× 95 0.7× 128 1.1× 105 0.9× 13 833
Volker Penndorf Germany 7 365 0.5× 252 0.4× 110 0.8× 67 0.6× 57 0.5× 10 514

Countries citing papers authored by Sarah Temple

Since Specialization
Citations

This map shows the geographic impact of Sarah Temple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Temple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Temple more than expected).

Fields of papers citing papers by Sarah Temple

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Temple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Temple. The network helps show where Sarah Temple may publish in the future.

Co-authorship network of co-authors of Sarah Temple

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Temple. A scholar is included among the top collaborators of Sarah Temple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Temple. Sarah Temple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Temple, Sarah, et al.. (2020). An evidence-based approach to abnormal vision in the emergency department. PubMed. 22(4). 1–28. 1 indexed citations
2.
Zou, Winnie Y., Hashem B. El‐Serag, Yvonne H. Sada, et al.. (2018). Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Digestive Diseases and Sciences. 63(5). 1173–1181. 16 indexed citations
3.
Zou, Winnie Y., Sarah Temple, Yvonne H. Sada, et al.. (2018). Tu1489 - Improved Treatment Delivery and Overall Survival Associated with Multidisciplinary Tumor Board Evaluation of Patients with Advanced Hepatocellular Carcinoma. Gastroenterology. 154(6). S–1236. 2 indexed citations
4.
Colorafi, Karen, et al.. (2018). Assessing Pneumococcal Vaccination Availability in Under-Vaccinated Rural Counties: A Pharmacy Perspective. The Consultant Pharmacist. 33(3). 163–170. 3 indexed citations
5.
Akce, Mehmet, Shubhada Sansgiry, Sarah Temple, Jessica A. Davila, & Yvonne H. Sada. (2017). The effect of treatment delay on survival in patients with hepatocellular cancer.. Journal of Clinical Oncology. 35(15_suppl). e15645–e15645. 5 indexed citations
6.
Mittal, Sahil, Fasiha Kanwal, Jun Ying, et al.. (2016). Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort. Journal of Hepatology. 65(6). 1148–1154. 108 indexed citations
7.
Khalaf, Natalia, Jun Ying, Sahil Mittal, et al.. (2016). Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance. Clinical Gastroenterology and Hepatology. 15(2). 273–281.e1. 107 indexed citations
8.
Khalaf, Natalia, Jun Ying, Sahil Mittal, et al.. (2016). Mo1494 Natural History of Untreated HCC in a U.S. Cohort and the Role of Cancer Surveillance. Gastroenterology. 150(4). S1130–S1130. 1 indexed citations
9.
Massarweh, Nader N., Jessica A. Davila, Hashem B. El‐Serag, et al.. (2015). Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard. Journal of Surgical Research. 200(2). 552–559. 16 indexed citations
10.
Mittal, Sahil, Hashem B. El‐Serag, Yvonne H. Sada, et al.. (2015). Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 14(1). 124–131.e1. 476 indexed citations breakdown →
11.
Mittal, Sahil, Yvonne H. Sada, Hashem B. El‐Serag, et al.. (2014). Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs Population. Clinical Gastroenterology and Hepatology. 13(3). 594–601.e1. 208 indexed citations
12.
Mittal, Sahil, Yvonne H. Sada, Hashem B. El‐Serag, et al.. (2014). Mo1035 Surveillance and Outcomes in Non-Alcoholic Fatty Liver Disease Related Hepatocellular Carcinoma in Veteran Affairs (VA) Population. Gastroenterology. 146(5). S–991. 1 indexed citations
13.
El‐Serag, Hashem B., Sahil Mittal, Fasiha Kanwal, et al.. (2014). 636 HCC in the Absence of Cirrhosis in United States Veterans: an Emerging Disease Entity Associated With Features of Metabolic Syndrome. Gastroenterology. 146(5). S–917. 2 indexed citations
14.
Davila, Jessica A., Yvonne H. Sada, Fasiha Kanwal, et al.. (2014). Tu1005 Outcomes Associated With Co-Utilization of VA and Medicare Healthcare Benefits in Patients With Hepatocellular Carcinoma. Gastroenterology. 146(5). S–1003. 1 indexed citations
15.
Fayad, Luis, Sarah Temple, Barbara Pro, et al.. (2007). R-HCVAD/R-MTX-ARAC is an effective regimen for untreated diffuse large B-cell lymphoma (DLBCL) with aggressive features: M. D. Anderson experience in 40 patients. Journal of Clinical Oncology. 25(18_suppl). 8058–8058. 1 indexed citations
16.
Hart, Glen, et al.. (2004). Tales of the River Bank, First Thoughts in the Development of a Topographic Ontology. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026